Research Study
View Full Study →
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
Citation
Fava M., Johe K., Ereshefsky L., Gertsik L., English B. et al. (2016). A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.. Molecular psychiatry. DOI: 10.1038/mp.2015.178
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.